Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12621000417886
Ethics application status
Approved
Date submitted
15/02/2021
Date registered
15/04/2021
Date last updated
15/04/2024
Date data sharing statement initially provided
15/04/2021
Type of registration
Prospectively registered
Titles & IDs
Public title
The effect of multi-day continuous theta-burst stimulation on symptoms of cervical dystonia
Query!
Scientific title
The effect of multi-day continuous theta-burst stimulation on symptoms of cervical dystonia in adults
Query!
Secondary ID [1]
303691
0
NIL known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Cervical dystonia
320743
0
Query!
Condition category
Condition code
Neurological
318581
318581
0
0
Query!
Other neurological disorders
Query!
Musculoskeletal
318895
318895
0
0
Query!
Other muscular and skeletal disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Participants will undergo 2 weeks (10 sessions) of continuous theta-burst stimulation (cTBS) to the somatosensory cortex (S1). Participants will be randomised before beginning the trial to receive either the intervention (cTBS) or a sham/placebo in the first block of sessions, and then the opposite form of stimulation in the second block of sessions (i.e., 20 sessions in total, separated into two blocks). The order of stimulation will be counterbalanced amongst participants. A washout period of approximately 2 weeks will separate the two blocks of sessions.
A Magventure Magpro R30 machine will be used to apply cTBS to the S1 bilaterally, which takes approximately 40 seconds each side. The cTBS intervention will consist of three pulses delivered at 50Hz every 200 milliseconds, for a total of 600 pulses.
The first, sixth, and last sessions in the intervention block are expected to take approximately 3 hours, due to the extra outcome measures collected (such as interhemispheric inhibition and single pulse TMS). The rest of the sessions are expected to take less than 30 minutes.
The intervention will take place at Deakin University's Cognitive Neuroscience Unit (Burwood). The intervention will be delivered by a student researcher and the principal investigator, who has over 5 years experience in TMS application.
Query!
Intervention code [1]
319740
0
Treatment: Devices
Query!
Comparator / control treatment
Participants will undergo 2 weeks (10 sessions) of sham cTBS to the S1. A Magventure Magpro R30 machine with a sham coil attached will be used to apply the sham cTBS to the S1 bilaterally, taking approximately 40 seconds per side. The first, sixth, and last sessions in the sham/placebo block are expected to take approximately 3 hours, due to the extra outcome measures collected (such as interhemispheric inhibition and single pulse TMS). The rest of the sessions are expected to take less than 30 minutes.
The intervention will take place at Deakin University's Cognitive Neuroscience Unit (Burwood). The intervention will be delivered by a student researcher and the principal investigator, who has over 5 years experience in TMS application.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
326540
0
Changes to average Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) score - clinical rating scale used to measure cervical dystonia symptoms.
Query!
Assessment method [1]
326540
0
Query!
Timepoint [1]
326540
0
The TWSTRS will be measured both before and after the intervention in each session.
Query!
Primary outcome [2]
326541
0
A composite measure which will assess changes to the range of motion, angle, tilt and position of a participants head and neck in space, as measured through a custom-made neck kinematics device.
Query!
Assessment method [2]
326541
0
Query!
Timepoint [2]
326541
0
The range of motion of a participants head and neck will be measured both before and after the intervention in each session.
Query!
Secondary outcome [1]
392832
0
Finger-to-nose dysmetria test, which will be assessed whilst the participant is wearing the neck kinematics device, to measure proprioception.
Query!
Assessment method [1]
392832
0
Query!
Timepoint [1]
392832
0
The dysmetria test will be conducted before and after the intervention in each session.
Query!
Secondary outcome [2]
408725
0
Changes to fMRI data, to determine if there are objective functional or structural changes in a participants brain, after the application of cTBS. The fMRI will be acquired whilst the participant is at rest (no task).
Query!
Assessment method [2]
408725
0
Query!
Timepoint [2]
408725
0
The participant will undergo a scan before and after one block of the intervention..
Query!
Secondary outcome [3]
408726
0
Changes to DWI data (white matter microstructure within the brain), to determine if there are objective structural changes within a participants brain, after the application of cTBS.
Query!
Assessment method [3]
408726
0
Query!
Timepoint [3]
408726
0
A scan will take place before and after one block of the intervention.
Query!
Eligibility
Key inclusion criteria
To be included in the study participants must be cervical dystonia patients aged 18 to 85, diagnosed by a physician with cervical dystonia 12 or more months ago. Participants must have had a subjective response to botulinum toxin treatment at some point, with their last botulinum toxin injection 2 or more months ago.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
85
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Severe head tremor, trauma to head or neck < 12 months prior to onset of dystonia, acquired dystonia (i.e., dystonia as a result of a traumatic brain injury, drug-induced, or as a result of another neurological condition), or pronounced head or neck tremor when lying down with neck supported.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Crossover
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
The projected sample size was guided by similar previous research which examined the effect of multi-day TBS to the cerebellum of cervical dystonia patients (Bradnam et al., 2016; Koch et al., 2014). For a significant difference between pre and post-intervention TWSTRS scores, moderate effect sizes of d=0.31 (Koch et al., 2014) and d=0.42 (Bradnam et al., 2016) were reported. Working under the assumption that lesion network mapping increases efficacy for selection of treatment targets, a large effect size (d=0.8) was estimated for this study. Assuming 80% power (alpha level of 0.05), G*power indicated a sample size of 20 participants will be required.
A two-way ANOVA will be conducted, and will explore the relationship between the primary outcome measure (TWSTRS), time, and treatment. The factors will be time and treatment, with two levels to each variable – baseline and post-intervention for time, and sham or cTBS for treatment.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
3/05/2021
Query!
Actual
29/03/2022
Query!
Date of last participant enrolment
Anticipated
27/09/2024
Query!
Actual
Query!
Date of last data collection
Anticipated
13/12/2024
Query!
Actual
Query!
Sample size
Target
20
Query!
Accrual to date
7
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment postcode(s) [1]
37359
0
3125 - Burwood
Query!
Funding & Sponsors
Funding source category [1]
307858
0
University
Query!
Name [1]
307858
0
Deakin University
Query!
Address [1]
307858
0
221 Burwood Highway
Burwood
VIC 3125
Query!
Country [1]
307858
0
Australia
Query!
Funding source category [2]
316304
0
Charities/Societies/Foundations
Query!
Name [2]
316304
0
Dystonia Coalition
Query!
Address [2]
316304
0
Query!
Country [2]
316304
0
United States of America
Query!
Primary sponsor type
University
Query!
Name
Deakin University - Australian Government Research Training Program Scholarship
Query!
Address
221 Burwood Highway
Burwood
VIC 3125
Query!
Country
Australia
Query!
Secondary sponsor category [1]
308580
0
None
Query!
Name [1]
308580
0
Query!
Address [1]
308580
0
Query!
Country [1]
308580
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
307862
0
Deakin University Human Research Ethics Committee
Query!
Ethics committee address [1]
307862
0
221 Burwood Highway Burwood VIC 3125
Query!
Ethics committee country [1]
307862
0
Australia
Query!
Date submitted for ethics approval [1]
307862
0
14/04/2021
Query!
Approval date [1]
307862
0
02/03/2022
Query!
Ethics approval number [1]
307862
0
Query!
Summary
Brief summary
Dystonia is a neurological disorder causing involuntary muscle contractions, and is thought to be caused by abnormal firing of specific brain networks. There are a number of types of dystonia, each defined by the body region/s that are affected. For example, and relevant to the present application, cervical dystonia (CD) affects the muscles of the neck. The current ‘gold standard’ treatments for CD are the injection of botulinum toxin type A (botox) into the affected muscles, or deep brain stimulation via brain surgery in more severe cases. However, injections only treat patients’ symptoms, rather than the underlying substrate of the disorder, and include side effects such as muscle wasting, while surgery is invasive and can be risky. As such, new treatments for CD are needed. Repetitive transcranial magnetic stimulation (rTMS) has shown some promise in patients with CD, however, overall results have not yet been compelling enough to carry rTMS forward as an approved treatment method. rTMS in CD has been hindered by the fact that the particular brain region that should be stimulated is still unknown. This is because previous neuroimaging findings have identified many different brain regions as abnormal in CD. This research will build upon findings by Corp et al. (2019), who demonstrated that the somatosensory cortex is abnormal in CD patients. Thus, this will be the first study to investigate whether a form of rTMS (called continuous theta-burst stimulation, or cTBS) to this brain region can effectively relieve CD symptoms. Aim 1 of the project is to investigate whether cTBS is an effective treatment for CD symptoms. It is hypothesised that there will be a significant overall reduction in CD symptoms post-intervention, as measured by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS). CD symptoms will also be measured through kinematic testing using a custom-made device to measure head and neck angle, tilt, and position. Aim 2 of this study is to investigate neurophysiological changes within the somatosensory cortex, due to the application of cTBS. It is hypothesised that there will be significant changes in the excitability of the somatosensory cortex (as measured by IHI) after the application of real cTBS in comparison to sham stimulation. Further, it is hypothesised that there will be a correlation between these changes in excitability, and reductions in CD symptom scores (as measured by the TWSTRS).
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
108738
0
Dr Daniel Corp
Query!
Address
108738
0
Deakin University
Cognitive Neuroscience Unit (CNU)
Building BC, Level 5
221 Burwood Highway
Burwood
VIC 3125
Query!
Country
108738
0
Australia
Query!
Phone
108738
0
+61 3 924 43019
Query!
Fax
108738
0
Query!
Email
108738
0
[email protected]
Query!
Contact person for public queries
Name
108739
0
Jordan Morrison-Ham
Query!
Address
108739
0
Deakin University
Cognitive Neuroscience Unit (CNU)
Building BC, Level 5
221 Burwood Highway
Burwood
VIC 3125
Query!
Country
108739
0
Australia
Query!
Phone
108739
0
+61 3 924 43019
Query!
Fax
108739
0
Query!
Email
108739
0
[email protected]
Query!
Contact person for scientific queries
Name
108740
0
Jordan Morrison-Ham
Query!
Address
108740
0
Deakin University
Cognitive Neuroscience Unit (CNU)
Building BC, Level 5
221 Burwood Highway
Burwood
VIC 3125
Query!
Country
108740
0
Australia
Query!
Phone
108740
0
+61 3 924 43019
Query!
Fax
108740
0
Query!
Email
108740
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
11009
Informed consent form
[email protected]
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF